1887

Microbial Genomics logo

Volume 7, Issue 11

Molecular epidemiology and phylogenomic analysis of clinical isolates in an Asian population Open Access

Abstract

comprises three subspecies . These closely related strains are typically multi-drug-resistant and can cause difficult-to-treat infections. Dominant clusters of isolates with increased pathogenic potential have been demonstrated in pulmonary infections in the global cystic fibrosis (CF) population. An investigation was performed on isolates cultured from an Asian, predominantly non-CF population to explore the phylogenomic relationships within our population and compare it to global isolates. Whole-genome-sequencing was performed on isolates between 2017 and 2019. Bioinformatic analysis was performed to determine multi-locus-sequence-type, to establish the phylogenetic relationships between isolates, and to identify virulence and resistance determinants in these isolates. A total of 210 isolates were included, of which 68.5 % (144/210) were respiratory samples. These isolates consisted of 140 (66.6 %) . subsp. , 67 (31.9 %) . subsp. abscessus and three (1.4 %) . subsp. . Dominant sequence-types in our population were similar to those of global CF isolates, but SNP differences in our population were comparatively wider despite the isolates being from the same geographical region. ESX (ESAT-6 secretory) cluster three appeared to occur most commonly in ST4 and ST6 subsp. , but other virulence factors did not demonstrate an association with isolate subspecies or sample source. We demonstrate that although similar predominant sequence-types are seen in our patient population, cross-transmission is absent. The risk of patient-to-patient transmission appears to be largely limited to the vulnerable CF population, indicating infection from environmental sources remains more common than human-to-human transmission. Resistance and virulence factors are largely consistent across the subspecies with the exception of clarithromycin susceptibility and ESX-3.

  • Received:
  • Accepted:
  • Published Online:
Keyword(s): genomic epidemiology , Mycobacterium abscessus complex , Mycobacterium bolletii , Mycobacterium massiliense and whole genome sequencing
Funding
This study was supported by the:
  • National University of Singapore
    • Principle Award Recipient: KaLip Chew
  • National Medical Research Council (Award CoSTAR-HS/ARGSeedGrant/2019/03)
    • Principle Award Recipient: KaLip Chew
© 2021 The Authors
  • This is an open-access article distributed under the terms of the Creative Commons Attribution License.
Loading

Article metrics loading...

/content/journal/mgen/10.1099/mgen.0.000708
2021-11-30
2024-04-16
Loading full text...

Full text loading...

/deliver/fulltext/mgen/7/11/mgen000708.html?itemId=/content/journal/mgen/10.1099/mgen.0.000708&mimeType=html&fmt=ahah

References

  1. Mougari F, Guglielmetti L, Raskine L, Sermet-Gaudelus I, Veziris N et al. Infections caused by Mycobacterium abscessus: epidemiology, diagnostic tools and treatment. Expert Rev Anti Infect Ther 2016; 14:1139–1154 [View Article] [PubMed]
     [Google Scholar]
  2. Haworth CS, Banks J, Capstick T, Fisher AJ, Gorsuch T et al. British Thoracic Society Guidelines for the Management of Non-tuberculous Mycobacterial Pulmonary Disease (NTM-PD). Thorax 2017; 72:ii1–ii64 [View Article] [PubMed]
     [Google Scholar]
  3. Daley CL et al. Treatment of nontuberculous mycobacterial pulmonary disease: an official ATS / ERS / ESCMID / IDSA clinical practice guideline. Clin Infect Dis 2020; 71:1–36
     [Google Scholar]
  4. Bryant JM, Grogono DM, Rodriguez-Rincon D, Everall I, Brown KP et al. Emergence and spread of a human-transmissible multidrug-resistant nontuberculous mycobacterium. Science 2016; 354:751–757 [View Article] [PubMed]
     [Google Scholar]
  5. Lipworth S, Hough N, Weston N, Muller-Pebody B, Phin N et al. Epidemiology of Mycobacterium abscessus in England: an observational study. The Lancet Microbe 2021; 2:e498–e507 [View Article]
     [Google Scholar]
  6. Yan J, Kevat A, Martinez E, Teese N, Johnson K et al. Investigating transmission of Mycobacterium abscessus amongst children in an Australian cystic fibrosis centre. J Cyst Fibros 2020; 19:219–224 [View Article] [PubMed]
     [Google Scholar]
  7. Redondo N, Mok S, Montgomery L, Flanagan PR, McNamara E et al. Genomic analysis of Mycobacterium abscessus complex isolates collected in Ireland between 2006 and 2017. J Clin Microbiol 2020; 58:e00295-20 [View Article] [PubMed]
     [Google Scholar]
  8. Ripoll F, Pasek S, Schenowitz C, Dossat C, Barbe V et al. Non mycobacterial virulence genes in the genome of the emerging pathogen Mycobacterium abscessus. PLoS ONE 2009; 4:e5660 [View Article] [PubMed]
     [Google Scholar]
  9. Johansen MD, Herrmann JL, Kremer L. Non-tuberculous mycobacteria and the rise of Mycobacterium abscessus. Nat Rev Microbiol 2020; 18:392–407 [View Article] [PubMed]
     [Google Scholar]
  10. Singh M, Rebordosa C, Bernholz J, Sharma N. Epidemiology and genetics of cystic fibrosis in Asia: In preparation for the next-generation treatments. Respirology 2015; 20:1172–1181 [View Article] [PubMed]
     [Google Scholar]
  11. Chew KL, Octavia S, Go J, Ng S, Tang YE et al. In vitro susceptibility of Mycobacterium abscessus complex and feasibility of standardizing treatment regimens. J Antimicrob Chemother 2021; 76:973–978 [View Article] [PubMed]
     [Google Scholar]
  12. CLSI Susceptibility Testing of Mycobacteria, Nocardia spp., and Other Aerobic Actinomycetes, 3rd ed. CLSI Standard M24; 2018
  13. Bolger AM, Lohse M, Usadel B. Trimmomatic: A flexible trimmer for Illumina sequence data. Bioinformatics 2014; 30:2114–2120 [View Article] [PubMed]
     [Google Scholar]
  14. Bankevich A, Nurk S, Antipov D, Gurevich AA, Dvorkin M et al. SPAdes: a new genome assembly algorithm and its applications to single-cell sequencing. J Comput Biol 2012; 19:455–477 [View Article] [PubMed]
     [Google Scholar]
  15. Seemann T. Prokka: Rapid prokaryotic genome annotation. Bioinformatics 2014; 30:2068–2069 [View Article] [PubMed]
     [Google Scholar]
  16. Price MN, Dehal PS, Arkin AP. FastTree: Computing Large Minimum Evolution Trees with Profiles instead of a Distance Matrix. Mol Biol Evol 2009261641–1650 [View Article] [PubMed]
     [Google Scholar]
  17. Letunic I, Bork P. Interactive tree of life (iTOL) v3: an online tool for the display and annotation of phylogenetic and other trees. Nucleic Acids Res 2016; 44:W242–5 [View Article] [PubMed]
     [Google Scholar]
  18. Bastian S, Veziris N, Roux A-L, Brossier F, Gaillard J-L et al. Assessment of clarithromycin susceptibility in strains belonging to the Mycobacterium abscessus group by erm (41) and rrl sequencing. Antimicrob Agents Chemother 2011; 55:775–781 [View Article]
     [Google Scholar]
  19. Nash KA, Brown-Elliott BA, Wallace RJ Jr. A novel gene, erm (41), confers inducible macrolide resistance to clinical isolates of Mycobacterium abscessus but is absent from Mycobacterium chelonae. Antimicrob Agents Chemother 2009; 53:1367–1376 [View Article]
     [Google Scholar]
  20. Brown-Elliott BA, Vasireddy S, Vasireddy R, Iakhiaeva E, Howard ST et al. Utility of sequencing the erm(41) gene in isolates of Mycobacterium abscessus subsp. abscessus with low and intermediate clarithromycin MICs. J Clin Microbiol 2015; 53:1211–1215 [View Article] [PubMed]
     [Google Scholar]
  21. Wu M, Li B, Guo Q, Xu L, Zou Y et al. Detection and molecular characterisation of amikacin-resistant Mycobacterium abscessus isolated from patients with pulmonary disease. J Glob Antimicrob Resist 2019; 19:188–191 [View Article] [PubMed]
     [Google Scholar]
  22. Luthra S, Rominski A, Sander P. The role of antibiotic-target-modifying and antibiotic-modifying enzymes in Mycobacterium abscessus drug resistance. Front Microbiol 2018; 9:2179 [View Article] [PubMed]
     [Google Scholar]
  23. Gutiérrez AV, Richard M, Roquet-Banères F, Viljoen A, Kremer L. The TetR family transcription factor MAB_2299c regulates the expression of two distinct MmpS-MmpL efflux pumps involved in cross-resistance to clofazimine and bedaquiline in Mycobacterium abscessus. Antimicrob Agents Chemother 2019; 63:e01000-19 [View Article] [PubMed]
     [Google Scholar]
  24. Chen Y, Chen J, Zhang S, Shi W, Zhang W et al. Novel mutations associated with clofazimine resistance in Mycobacterium abscessus. Antimicrob Agents Chemother 2018; 62:e00544-18 [View Article] [PubMed]
     [Google Scholar]
  25. Rudra P, Hurst-Hess K, Lappierre P, Ghosh P. High levels of intrinsic tetracycline resistance in Mycobacterium abscessus are conferred by a tetracycline-modifying monooxygenase. Antimicrob Agents Chemother 2018; 62:e00119–18 [View Article]
     [Google Scholar]
  26. Rominski A, Roditscheff A, Selchow P, Böttger EC, Sander P. Intrinsic rifamycin resistance of Mycobacterium abscessus is mediated by ADP-ribosyltransferase MAB_0591. J Antimicrob Chemother 2017; 72:376–384 [View Article] [PubMed]
     [Google Scholar]
  27. Chew KL, Cheng JWS, Hudaa Osman N, Lin RTP, Teo JWP. Predominance of clarithromycin-susceptible Mycobacterium massiliense subspecies: Characterization of the Mycobacterium abscessus complex at a tertiary acute care hospital. J Med Microbiol 2017; 66:1443–1447 [View Article] [PubMed]
     [Google Scholar]
  28. Kim H-Y, Kook Y, Yun Y-J, Park CG, Lee NY et al. Proportions of Mycobacterium massiliense and Mycobacterium bolletii strains among Korean Mycobacterium chelonae-Mycobacterium abscessus group isolates. J Clin Microbiol 2008; 46:3384–3390 [View Article] [PubMed]
     [Google Scholar]
  29. Chua KYL, Bustamante A, Jelfs P, Chen S-A, Sintchenko V. Antibiotic susceptibility of diverse Mycobacterium abscessus complex strains in New South Wales, Australia. Pathology 2015; 47:678–682 [View Article] [PubMed]
     [Google Scholar]
  30. Lee M-C, Sun P-L, Wu T-L, Wang L-H, Yang C-H et al. Antimicrobial resistance in Mycobacterium abscessus complex isolated from patients with skin and soft tissue infections at a tertiary teaching hospital in Taiwan. J Antimicrob Chemother 2017; 72:2782–2786 [View Article]
     [Google Scholar]
  31. Jeong SH, Kim S-Y, Huh HJ, Ki C-S, Lee NY et al. Mycobacteriological characteristics and treatment outcomes in extrapulmonary Mycobacterium abscessus complex infections. Int J Infect Dis 2017; 60:49–56 [View Article] [PubMed]
     [Google Scholar]
  32. Kamada K, Yoshida A, Iguchi S, Arai Y, Uzawa Y et al. Geographical distribution and regional differences in 532 clinical isolates of rapidly growing mycobacterial species in Japan. Sci Rep 2021; 11:4960 [View Article] [PubMed]
     [Google Scholar]
  33. dos Santos Carneiro M, de Souza Nunes L, Martini de David SM, Barth AL. Lack of association between rrl and erm(41) mutations and clarithromycin resistance in Mycobacterium abscessus complex. Mem Inst Oswaldo Cruz 2017; 112:775–778 [View Article]
     [Google Scholar]
  34. Maurer FP, Rüegger V, Ritter C, Bloemberg GV, Böttger EC. Acquisition of clarithromycin resistance mutations in the 23S rRNA gene of Mycobacterium abscessus in the presence of inducible erm(41. J Antimicrob Chemother 2012; 67:2606–2611 [View Article] [PubMed]
     [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/mgen/10.1099/mgen.0.000708
Loading
Molecular epidemiology and phylogenomic analysis of Mycobacterium abscessus clinical isolates in an Asian population
M Gen 7, 000708 (2021); https://doi.org/10.1099/mgen.0.000708
/content/journal/mgen/10.1099/mgen.0.000708
/content/journal/mgen/10.1099/mgen.0.000708
Loading

Data & Media loading...

Supplements

Supplementary material 1

EXCEL

Most cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error